 |
PDBsum entry 1bd9
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Lipid binding protein
|
PDB id
|
|
|
|
1bd9
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Structure
6:1245-1254
(1998)
|
|
PubMed id:
|
|
|
|
|
| |
|
Function from structure? The crystal structure of human phosphatidylethanolamine-binding protein suggests a role in membrane signal transduction.
|
|
M.J.Banfield,
J.J.Barker,
A.C.Perry,
R.L.Brady.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
BACKGROUND: Proteins belonging to the phosphatidylethanolamine-binding protein
(PEBP) family are highly conserved throughout nature and have no significant
sequence homology with other proteins of known structure or function. A variety
of biological roles have previously been described for members of this family,
including lipid binding, roles as odorant effector molecules or opioids,
interaction with the cell-signalling machinery, regulation of flowering plant
stem architecture, and a function as a precursor protein of a bioactive brain
neuropeptide. To date, no experimentally derived structural information has been
available for this protein family. In this study we have used X-ray
crystallography to determine the three-dimensional structure of human PEBP
(hPEBP), in an attempt to clarify the biological role of this unique protein
family. RESULTS: The crystal structures of two forms of hPEBP have been
determined: one in the native state (at 2.05 A resolution) and one in complex
with cacodylate (at 1.75 A resolution). The crystal structures reveal that hPEBP
adopts a novel protein topology, dominated by the presence of a large central
beta sheet, and is expected to represent the archaetypal fold for this family of
proteins. Two potential functional sites have been identified from the
structure: a putative ligand-binding site and a coupled cleavage site. hPEBP
forms a dimer in the crystal with a distinctive dipole moment that may orient
the oligomer for membrane binding. CONCLUSIONS: The crystal structure of hPEBP
suggests that the ligand-binding site could accommodate the phosphate head
groups of membrane lipids, therefore allowing the protein to adhere to the inner
leaf of bilipid membranes where it would be ideally positioned to relay signals
from the membrane to the cytoplasm. The structure also suggests that ligand
binding may lead to coordinated release of the N-terminal region of the protein
to form the hippocampal neurostimulatory peptide, which is known to be active in
the development of the hippocampus. These studies are consistent with a primary
biological role for hPEBP as a transducer of signals from the interior membrane
surface.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
Figure 3.
Figure 3. Secondary structure elements in hPEBP. (a) The
putative dimer of hPEBP formed by the two molecules in the
asymmetric unit of the crystal. Also shown (arrow) is the
approximate direction of the dipole moment for the hPEBP dimer,
which suggests an orientation for the oligomer to interact with
the membrane. The molecules of cacodylate present in the
ligand-bound structure are shown in CPK representation. (b)
Schematic topology diagram illustrating the arrangement of
secondary structure in the hPEBP monomer. β Strands (shown in
cyan) are labelled with lower-case letters and correspond to
immunoglobulin/fibronectin type III conventions, as discussed in
the text; α helices (shown in red) are labelled with upper-case
letters. (The figures were prepared using the program MOLSCRIPT
[32] and rendered using Raster3D [33].)
|
 |
|
|
|
| |
The above figure is
reprinted
by permission from Cell Press:
Structure
(1998,
6,
1245-1254)
copyright 1998.
|
|
| |
Figure was
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
C.Yi,
Y.Peng,
C.Guo,
and
D.Lin
(2011).
(1)H, ( 13)C, ( 15)N backbone and side-chain resonance assignments of the human Raf-1 kinase inhibitor protein.
|
| |
Biomol NMR Assign,
5,
63-66.
|
 |
|
|
|
|
 |
A.N.Shemon,
G.L.Heil,
A.E.Granovsky,
M.M.Clark,
D.McElheny,
A.Chimon,
M.R.Rosner,
and
S.Koide
(2010).
Characterization of the Raf kinase inhibitory protein (RKIP) binding pocket: NMR-based screening identifies small-molecule ligands.
|
| |
PLoS One,
5,
e10479.
|
 |
|
|
|
|
 |
L.Ruan,
G.L.Wang,
H.Yi,
Y.Chen,
C.E.Tang,
P.F.Zhang,
M.Y.Li,
C.Li,
F.Peng,
J.L.Li,
Z.C.Chen,
and
Z.Q.Xiao
(2010).
Raf kinase inhibitor protein correlates with sensitivity of nasopharyngeal carcinoma to radiotherapy.
|
| |
J Cell Biochem,
110,
975-981.
|
 |
|
|
|
|
 |
A.E.Granovsky,
M.C.Clark,
D.McElheny,
G.Heil,
J.Hong,
X.Liu,
Y.Kim,
G.Joachimiak,
A.Joachimiak,
S.Koide,
and
M.R.Rosner
(2009).
Raf kinase inhibitory protein function is regulated via a flexible pocket and novel phosphorylation-dependent mechanism.
|
| |
Mol Cell Biol,
29,
1306-1320.
|
 |
|
|
|
|
 |
A.N.Shemon,
E.M.Eves,
M.C.Clark,
G.Heil,
A.Granovsky,
L.Zeng,
A.Imamoto,
S.Koide,
and
M.R.Rosner
(2009).
Raf Kinase Inhibitory Protein protects cells against locostatin-mediated inhibition of migration.
|
| |
PLoS One,
4,
e6028.
|
 |
|
|
|
|
 |
G.Rautureau,
L.Jouvensal,
F.Vovelle,
F.Schoentgen,
D.Locker,
and
M.Decoville
(2009).
Expression and characterization of the PEBP homolog genes from Drosophila.
|
| |
Arch Insect Biochem Physiol,
71,
55-69.
|
 |
|
|
|
|
 |
J.Klysik,
S.J.Theroux,
J.M.Sedivy,
J.S.Moffit,
and
K.Boekelheide
(2008).
Signaling crossroads: the function of Raf kinase inhibitory protein in cancer, the central nervous system and reproduction.
|
| |
Cell Signal,
20,
1-9.
|
 |
|
|
|
|
 |
K.M.Woods Ignatoski,
N.K.Grewal,
S.M.Markwart,
A.Vellaichamy,
A.M.Chinnaiyan,
K.Yeung,
M.E.Ray,
and
E.T.Keller
(2008).
Loss of Raf kinase inhibitory protein induces radioresistance in prostate cancer.
|
| |
Int J Radiat Oncol Biol Phys,
72,
153-160.
|
 |
|
|
|
|
 |
H.Fukada,
J.Mima,
M.Nagayama,
M.Kato,
and
M.Ueda
(2007).
Biochemical analysis of the yeast proteinase inhibitor (IC) homolog ICh and its comparison with IC.
|
| |
Biosci Biotechnol Biochem,
71,
472-480.
|
 |
|
|
|
|
 |
W.Q.Chen,
A.Viidik,
M.Skalicky,
H.Höger,
and
G.Lubec
(2007).
Hippocampal signaling cascades are modulated in voluntary and treadmill exercise rats.
|
| |
Electrophoresis,
28,
4392-4400.
|
 |
|
|
|
|
 |
Y.Yamada,
N.N.Suzuki,
T.Hanada,
Y.Ichimura,
H.Kumeta,
Y.Fujioka,
Y.Ohsumi,
and
F.Inagaki
(2007).
The crystal structure of Atg3, an autophagy-related ubiquitin carrier protein (E2) enzyme that mediates Atg8 lipidation.
|
| |
J Biol Chem,
282,
8036-8043.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
B.Nixon,
D.A.MacIntyre,
L.A.Mitchell,
G.M.Gibbs,
M.O'Bryan,
and
R.J.Aitken
(2006).
The identification of mouse sperm-surface-associated proteins and characterization of their ability to act as decapacitation factors.
|
| |
Biol Reprod,
74,
275-287.
|
 |
|
|
|
|
 |
H.C.Lee,
B.Tian,
J.M.Sedivy,
J.R.Wands,
and
M.Kim
(2006).
Loss of Raf kinase inhibitor protein promotes cell proliferation and migration of human hepatoma cells.
|
| |
Gastroenterology,
131,
1208-1217.
|
 |
|
|
|
|
 |
J.H.Ahn,
D.Miller,
V.J.Winter,
M.J.Banfield,
J.H.Lee,
S.Y.Yoo,
S.R.Henz,
R.L.Brady,
and
D.Weigel
(2006).
A divergent external loop confers antagonistic activity on floral regulators FT and TFL1.
|
| |
EMBO J,
25,
605-614.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
J.Mima,
H.Fukada,
M.Nagayama,
and
M.Ueda
(2006).
Specific membrane binding of the carboxypeptidase Y inhibitor I(C), a phosphatidylethanolamine-binding protein family member.
|
| |
FEBS J,
273,
5374-5383.
|
 |
|
|
|
|
 |
P.Sarkar,
S.Sarkar,
V.Ramesh,
B.E.Hayes,
R.L.Thomas,
B.L.Wilson,
H.Kim,
S.Barnes,
A.Kulkarni,
N.Pellis,
and
G.T.Ramesh
(2006).
Proteomic analysis of mice hippocampus in simulated microgravity environment.
|
| |
J Proteome Res,
5,
548-553.
|
 |
|
|
|
|
 |
E.T.Keller,
Z.Fu,
and
M.Brennan
(2005).
The biology of a prostate cancer metastasis suppressor protein: Raf kinase inhibitor protein.
|
| |
J Cell Biochem,
94,
273-278.
|
 |
|
|
|
|
 |
F.Chardon,
and
C.Damerval
(2005).
Phylogenomic analysis of the PEBP gene family in cereals.
|
| |
J Mol Evol,
61,
579-590.
|
 |
|
|
|
|
 |
N.Trakul,
and
M.R.Rosner
(2005).
Modulation of the MAP kinase signaling cascade by Raf kinase inhibitory protein.
|
| |
Cell Res,
15,
19-23.
|
 |
|
|
|
|
 |
Y.Hanzawa,
T.Money,
and
D.Bradley
(2005).
A single amino acid converts a repressor to an activator of flowering.
|
| |
Proc Natl Acad Sci U S A,
102,
7748-7753.
|
 |
|
|
|
|
 |
H.Chautard,
M.Jacquet,
F.Schoentgen,
N.Bureaud,
and
H.Bénédetti
(2004).
Tfs1p, a member of the PEBP family, inhibits the Ira2p but not the Ira1p Ras GTPase-activating protein in Saccharomyces cerevisiae.
|
| |
Eukaryot Cell,
3,
459-470.
|
 |
|
|
|
|
 |
J.Mima,
M.Hayashida,
T.Fujii,
Y.Hata,
R.Hayashi,
and
M.Ueda
(2004).
Crystallization and preliminary X-ray analysis of carboxypeptidase Y inhibitor IC complexed with the cognate proteinase.
|
| |
Acta Crystallogr D Biol Crystallogr,
60,
1622-1624.
|
 |
|
|
|
|
 |
Y.Goumon,
T.Angelone,
F.Schoentgen,
S.Chasserot-Golaz,
B.Almas,
M.M.Fukami,
K.Langley,
I.D.Welters,
B.Tota,
D.Aunis,
and
M.H.Metz-Boutigue
(2004).
The hippocampal cholinergic neurostimulating peptide, the N-terminal fragment of the secreted phosphatidylethanolamine-binding protein, possesses a new biological activity on cardiac physiology.
|
| |
J Biol Chem,
279,
13054-13064.
|
 |
|
|
|
|
 |
B.S.Vallée,
G.Coadou,
H.Labbé,
D.Sy,
F.Vovelle,
and
F.Schoentgen
(2003).
Peptides corresponding to the N- and C-terminal parts of PEBP are well-structured in solution: new insights into their possible interaction with partners in vivo.
|
| |
J Pept Res,
61,
47-57.
|
 |
|
|
|
|
 |
J.Mima,
Y.Narita,
H.Chiba,
and
R.Hayashi
(2003).
The multiple site binding of carboxypeptidase Y inhibitor (IC) to the cognate proteinase. Implications for the biological roles of the phosphatidylethanolamine-binding protein.
|
| |
J Biol Chem,
278,
29792-29798.
|
 |
|
|
|
|
 |
P.C.Simister,
M.J.Banfield,
and
R.L.Brady
(2002).
The crystal structure of PEBP-2, a homologue of the PEBP/RKIP family.
|
| |
Acta Crystallogr D Biol Crystallogr,
58,
1077-1080.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
B.S.Vallée,
P.Tauc,
J.C.Brochon,
R.Maget-Dana,
D.Lelièvre,
M.H.Metz-Boutigue,
N.Bureaud,
and
F.Schoentgen
(2001).
Behaviour of bovine phosphatidylethanolamine-binding protein with model membranes. Evidence of affinity for negatively charged membranes.
|
| |
Eur J Biochem,
268,
5831-5841.
|
 |
|
|
|
|
 |
K.C.Yeung,
D.W.Rose,
A.S.Dhillon,
D.Yaros,
M.Gustafsson,
D.Chatterjee,
B.McFerran,
J.Wyche,
W.Kolch,
and
J.M.Sedivy
(2001).
Raf kinase inhibitor protein interacts with NF-kappaB-inducing kinase and TAK1 and inhibits NF-kappaB activation.
|
| |
Mol Cell Biol,
21,
7207-7217.
|
 |
|
|
|
|
 |
N.Mimida,
K.Goto,
Y.Kobayashi,
T.Araki,
J.H.Ahn,
D.Weigel,
M.Murata,
F.Motoyoshi,
and
W.Sakamoto
(2001).
Functional divergence of the TFL1-like gene family in Arabidopsis revealed by characterization of a novel homologue.
|
| |
Genes Cells,
6,
327-336.
|
 |
|
|
|
|
 |
T.Kroslak,
T.Koch,
E.Kahl,
and
V.Höllt
(2001).
Human phosphatidylethanolamine-binding protein facilitates heterotrimeric G protein-dependent signaling.
|
| |
J Biol Chem,
276,
39772-39778.
|
 |
|
|
|
|
 |
J.H.Hurley,
Y.Tsujishita,
and
M.A.Pearson
(2000).
Floundering about at cell membranes: a structural view of phospholipid signaling.
|
| |
Curr Opin Struct Biol,
10,
737-743.
|
 |
|
|
|
|
 |
K.Carroll,
K.Ray,
B.Helm,
and
E.Carey
(2000).
Two-dimensional electrophoresis reveals differential protein expression in high- and low-secreting variants of the rat basophilic leukaemia cell line.
|
| |
Electrophoresis,
21,
2476-2486.
|
 |
|
|
|
|
 |
S.Steiner,
C.L.Gatlin,
J.J.Lennon,
A.M.McGrath,
A.M.Aponte,
A.J.Makusky,
M.C.Rohrs,
and
N.L.Anderson
(2000).
Proteomics to display lovastatin-induced protein and pathway regulation in rat liver.
|
| |
Electrophoresis,
21,
2129-2137.
|
 |
|
|
|
|
 |
Y.Kuramitsu,
M.Fujimoto,
T.Tanaka,
J.Ohata,
and
K.Nakamura
(2000).
Differential expression of phosphatidylethanol-amine-binding protein in rat hepatoma cell lines: analyses of tumor necrosis factor-alpha-resistant cKDH-8/11 and -sensitive KDH-8/YK cells by two-dimensional gel electrophoresis.
|
| |
Electrophoresis,
21,
660-664.
|
 |
|
|
|
|
 |
B.Vallée,
C.Teyssier,
R.Maget-Dana,
J.Ramstein,
N.Bureaud,
and
F.Schoentgen
(1999).
Stability and physicochemical properties of the bovine brain phosphatidylethanolamine-binding protein.
|
| |
Eur J Biochem,
266,
40-52.
|
 |
|
|
|
|
 |
I.Kardailsky,
V.K.Shukla,
J.H.Ahn,
N.Dagenais,
S.K.Christensen,
J.T.Nguyen,
J.Chory,
M.J.Harrison,
and
D.Weigel
(1999).
Activation tagging of the floral inducer FT.
|
| |
Science,
286,
1962-1965.
|
 |
|
|
|
|
 |
Y.Kobayashi,
H.Kaya,
K.Goto,
M.Iwabuchi,
and
T.Araki
(1999).
A pair of related genes with antagonistic roles in mediating flowering signals.
|
| |
Science,
286,
1960-1962.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |